May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Effects of intravitreal triamcinolone acetonide on diabetic retinal neovascularization
Author Affiliations & Notes
  • S. Ben Yahia
    Ophthalmology, Fattouma Bourguiba University Hospital, Monastir, Tunisia
  • H. Zeghidi
    Ophthalmology, Fattouma Bourguiba University Hospital, Monastir, Tunisia
  • S. Attia
    Ophthalmology, Fattouma Bourguiba University Hospital, Monastir, Tunisia
  • S. Zaouali
    Ophthalmology, Fattouma Bourguiba University Hospital, Monastir, Tunisia
  • A. Ladjimi
    Ophthalmology, Fattouma Bourguiba University Hospital, Monastir, Tunisia
  • M. Khairallah
    Ophthalmology, Fattouma Bourguiba University Hospital, Monastir, Tunisia
  • Footnotes
    Commercial Relationships  S. Ben Yahia, None; H. Zeghidi, None; S. Attia, None; S. Zaouali, None; A. Ladjimi, None; M. Khairallah, None.
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 4142. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S. Ben Yahia, H. Zeghidi, S. Attia, S. Zaouali, A. Ladjimi, M. Khairallah; Effects of intravitreal triamcinolone acetonide on diabetic retinal neovascularization . Invest. Ophthalmol. Vis. Sci. 2004;45(13):4142.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose:To evaluate the effects of intravitreal triamcinolone acetonide (TA) on diabetic retinal neovascularization. Methods:The study included 11 eyes of 10 patients with diabetic macular edema and associated retinal and/or optic disc neovascularization persisting after scatter laser photocoagulation. All patients received an intravitreal injection of 4 mg of TA. No additional laser photocoagulation was performed after TA injection. Evaluation before injection and throughout follow–up included measurement of best–corrected visual acuity, slit–lamp examination, fundus photography, and fluorescein angiography. Follow–up period ranged from 3 to 12 months (mean 6.4 months). Results:Mean visual acuity improved from 20/300 to 20/160 (p = 0.039). Macular edema diminished or resolved completely in all eyes. Neovascularization substantially regressed in 10 eyes (90.9%) and remained unchanged in one eye (9.1%). None of the eyes developed vitreous hemorrhage after treatment. An intraocular pressure elevation occurred in 3 eyes (27.3%), and was successfully treated by topical medication. No other complications, such as endophthalmitis or pseudo–endophthalmitis were recorded. Conclusions:Intravitreal injection of TA may be useful for the treatment of residual diabetic retinal neovascularization. Further studies are warranted to assess the long–term efficacy and safety, and the need for retreatment.

Keywords: retinal neovascularization • corticosteroids 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×